Search Clinical Pathways
Clinical Pathway for Pancreatic Enzyme Replacement Therapy (PERT) in Children with or at Risk for Exocrine Pancreatic Insufficiency (EPI)
Guidelines for evaluating patients suspected to have exocrine pancreatic insufficiency and initiating/optimizing pancreatic enzyme replacement therapy.
Inflammatory Bowel Disease with Iron Deficiency and Anemia Clinical Pathway — All Settings
Clinical Care Pathway for screening, management and follow up of iron deficiency and anemia among patients with Inflammatory Bowel Disease.
Therapeutic Hypothermia, Hypoxic Ischemic Encephalopathy (HIE) Clinical Pathway — N/IICU
This pathway provides guidance for identifying neonates symptomatic at or near the time of birth from Hypoxic-Ischemic Encephalopathy (HIE) who may be eligible whole body cooling.
Double Volume Exchange Transfusion Clinical Pathway — ICU
This pathway should be used to guide the management of infants requiring a double volume exchange transfusion
Evaluation of Suspected Acute Flaccid Myelitis Clinical Pathway — Emergency and Inpatient
This pathway guides the care of children who present with onset of flaccid weakness in one or more extremities +/- bulbar/cranial nerve findings without other clear cause.
Central Diabetes Insipidus (DI)/Arginine Vasopressin Deficiency (AVP-D) Clinical Pathway – PICU
The PICU central diabetes insipidus pathway provides guidance for the care of patients with known or suspected central diabetes insipidus requiring ICU care.
Trauma Nutrition Clinical Pathway — ICU
This pathway provides guidance for the care of patients at baseline risk for malnutrition and/or unlikely to consume adequate caloric intake by mouth within 3 days of admission to the ICU.
Neuromuscular Compromise and Respiratory Failure Clinical Pathway — Inpatient and PICU
This pathway is intended for use in the inpatient pulmonary service and the PICU to guide care for patients with common neurodegenerative conditions affecting respiratory status.
Upper Gastrointestinal Bleed Clinical Pathway — Emergency Department, ICU and Inpatient
This pathway guides the care for children in the ED, ICU or inpatient setting with signs and symptoms of UGI bleeding
Neonates with Hyperbilirubinemia/Jaundice Clinical Pathway
The hyperbilirubinemia pathway is a standard approach to initial evaluation, treatment, and management of infants with hyperbilirubinemia from birth through 21 days of life.